Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Conventional Dose Regimen and New Dose Regimen of Pregabalin

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pain score NRS ≥3 Patients complaining of neuropathic pain (except neuropathic pain due to chemotherapy)~* Adult patients aged 19 to 85 years~* Patients who pre-agreed to the study~Exclusion Criteria:~* Patients complaining of severe pain (NRS ≥ 8)~* Creatinine clearance of \<30 mL / min, the liver was more than 3 times normal~* Patients complaining of dizziness, patients with definite orthostatic hypotension~* Pregnant or lactating patients~* Patients who previously experienced side effects after administration pregabalin.

- Gender: ALL
- Minimum Age: 19 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Pregabalin 75mg bid (Type: ACTIVE_COMPARATOR): The patients who were prescribed according to the conventional flexible dose regimen
- pregabalin 25mg,50mg (Type: EXPERIMENTAL): The patients who were prescribed according to the new flexible dose regimen.

Based on this trial design, predict the completion outcome and termination type (if applicable).